Mepitiostane

Anti-MIER1 mesoderm induction early response 1, transcriptio

Anti-TNFRSF8 tumor necrosis factor receptor superfamily, mem

eIF4A3-IN-9 (compound 57) is a silvestrol ( HY-13251 ) analogue. eIF4A3-IN-9 interferes the assembling of eIF4F translation complex with EC 50 s of 29, 450 and 80 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-9

iCRT-14 is a novel potent inhibitor of β-catenin-responsive transcription (CRT) (IC50 = 40.3 nM in assays of Wnt pathway activity).A potent beta-catenin inhibitor.

Masofaniten (Androgen receptor-IN-2) is a potent and orally active androgen receptor inhibitor. Masofaniten has antitumor activity against prostate cancerIn VitroMasofaniten (compound A109, androgen-induced PSA-Luciferase assay) inhibits androgen

Masofaniten (Androgen receptor-IN-2) is a potent and orally active androgen receptor inhibitor. Masofaniten has antitumor activity against prostate cancerIn VitroMasofaniten (compound A109, androgen-induced PSA-Luciferase assay) inhibits androgen

Masofaniten (Androgen receptor-IN-2) is a potent and orally active androgen receptor inhibitor. Masofaniten has antitumor activity against prostate cancerIn VitroMasofaniten (compound A109, androgen-induced PSA-Luciferase assay) inhibits androgen

Biochem/physiol Actions Mephedrone is an inhibitor of monoamine transporter present in the brain and periphery. Mephedrone bears a chiral center and can be found in two enantiomers R-mephedrone and S-mephedrone.

Biochem/physiol Actions Mephedrone is an inhibitor of monoamine transporter present in the brain and periphery. Mephedrone bears a chiral center and can be found in two enantiomers R-mephedrone and S-mephedrone.

General description Mephedrone, also known as 4-methylmethcathinone, is a synthetic stimulant of the amphetamine and cathinone classes. Significant abuse of this new recreational drug has been reported within the last year in the UK: Sweden: and

NY2267 is a disruptor of Myc-Max interaction , with an IC 50 of 36.5 μM. NY2267 inhibits Myc- and Jun-induced transcriptional activation.In VitroNY2267 strongly inhibits oncogenic transformation induced by Myc. MCE has not independently confirmed